
Echo IQ:
Designed FOR
cardiologistS
Echo IQ uses proprietary artificial intelligence to help identify patients at risk of structural heart disease.
Echo IQ has developed a cloud-based decision-support software, EchoSolv™, powered by Artificial Intelligence and Machine Learning, which aims to provide physicians with a reliable tool to identify patients at-risk of structural heart disease who may benefit from further referral. EchoSolv™ aims to improve the current standard clinical workflow associated with diagnosis and treatment.


ACCURATE
- Consistent assessment with zero variability
- Comprehensive hemodynamic evaluation in under 3 seconds
UNBIASED
- Eliminate unconscious bias and standardize diagnosis across age, race, and sex
- Increase certainty in challenging cases, including LFLG
COMPREHENSIVE
- AI trained on the largest global database of echocardiograms linked to mortality with more than 200 million echo endpoints and validated against 220,000 patients.
“EchoSolv worked extremely well to identify individuals with severe aortic stenosis, despite needing minimal data inputs. Using EchoSolv in clinical practice could make a huge difference in our ability to identify those individuals who need timely evaluation.”
Prof. Jordan Strom.
Harvard Medical School Principal Investigator
Intervention shown to decrease risk of future hospitalisation and improve quality of life.
Request A Demo

EASY INTEGRATION
- No disruption to existing workflows
- Risk alerts to support easy interpretation
SECURITY
- HIPAA and SOCII compliant
FLEXIBILITY
- Can be used both retrospectively to review previous echos and live, with evaluation returned in
under 3 seconds
EchoSolv™ has been developed using what we believe to be the largest database of its kind anywhere in the world, with exclusive commercial access to the National Echocardiographic Database of Australia (NEDA). NEDA is a highly trusted and respected research database that collects echocardiographic measurements and associated health information from more than 35 leading hospitals. Most importantly, it is the only database of its size linked to mortality—a critical differentiator for structural heart disease.
The use of large cardiac datasets to develop solutions that advance risk detection for increasingly treatable conditions is incredibly exciting.
The application of new techniques such as machine learning and artificial intelligence to the world of cardiology creates significant opportunity to deliver meaningful improvements in diagnosis and treatment.
Applying new digital technologies to the detection and treatment of cardiovascular diseases has the potential to change the way we approach public healthcare delivery
The work being undertaken by Echo IQ utilizes novel approaches to the diagnosis of cardiovascular diseases that could potentially open treatment avenues for those in greatest need. The convergence of artificial intelligence, machine learning and novel techniques in echocardiography is incredibly exciting.
Featured on 9 News
Read the full story titled “How AI is helping with life-threatening heart diagnoses” or watch the video now on the 9 news website.
Echo IQ is proud to partner with leading institutions around the world, collaboratively creating new research innovations, commercial opportunities, and improving health outcomes.
Join us today.